NCT06705881 Efficacy of the Extracorporeal Shock Wave Therapy in Athletes With Patellar Tendinopathy
| NCT ID | NCT06705881 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ahi Evran University Education and Research Hospital |
| Condition | Patellar Tendinopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2024-12-01 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2024-12-01 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate the effectiveness of extracorporeal shock wave therapy (ESWT) in addition to eccentric exercise on the clinical outcomes of PT in the treatment of athletes with patellar tendinopathy (PT). Participants will be randomly divided into two groups. The intervention group will receive focus ESWT 3 times a week in addition to 6 weeks of exercise. The control group will be given 6 weeks of exercise. Evaluations will be made at the 3rd and 6th weeks, and at the 3rd, 6th and 12th months. Patient evaluation will begin with obtaining sociodemographic information. Patients' pain level will be assessed using visual analog scale (VAS), tendon pain and function VISA-P, functional capacity; The patients will be assessed with the maximal vertical jump test (MDS), single leg jump distance test (SLHD), single leg squat test (STS) on the incline board, pain catastrophe with the pain catastrophe scale (PCS), kinesiophobia with the Tampa Kinesiophobia Scale (TKS), quality of life short form-12 (SF-12) and physical activity level with the Tegner Activity Scale (TAS).
Eligibility Criteria
Inclusion Criteria: * Localized pain in the inferior pole of the patella during single-leg squatting due to load, * Pain or tenderness with palpation of the patellar tendon, * Complaints of pain in the patellar tendon due to training, competition or physical activity in the last 6 months, * Performing sports/physical activities related to jumping and landing, * Professional and recreational athletes who perform at least 5 and above according to the Tegner Activity score, * VISA-P scale score \<80 out of 100. Exclusion Criteria: * Presence of other knee pathologies, * Known presence of inflammatory joint diseases or familial hypercholesterolemia, * Daily use of drugs with presumed effects on the patellar tendon (e.g. fluoroquinolones) in the last 12 months, * Local injection therapy with corticosteroids in the last 12 months, * Previous patellar tendon rupture, * Any lower extremity surgery in the last 6 months.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06705881 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Patellar Tendinopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06705881 currently recruiting?
Yes, NCT06705881 is actively recruiting participants. Contact the research team at abdulhamit.tayfur@ahievran.edu.tr for enrollment information.
Where is the NCT06705881 trial being conducted?
This trial is being conducted at Kırşehir, Turkey (Türkiye).
Who is sponsoring the NCT06705881 clinical trial?
NCT06705881 is sponsored by Ahi Evran University Education and Research Hospital. The trial plans to enroll 32 participants.